Cita APA (7a ed.)

R, F., ME, C., HH, D., & JL, V. (2019). Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: Integrated analysis of two Phase III clinical studies. Dove Medical Press.

Cita Chicago Style (17a ed.)

R, Fong, Cavet ME, DeCory HH, y Vittitow JL. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.

Cita MLA (8a ed.)

R, Fong, et al. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.